Taste Properties of HIV Inhibitor

ViiV Healthcare logo

ViiV Healthcare

Status and phase

Completed
Phase 1

Conditions

HIV Infections

Treatments

Drug: BMS-955176

Study type

Interventional

Funder types

Industry

Identifiers

NCT02608918
AI468-065 (Other Identifier)
206301

Details and patient eligibility

About

The purpose of the study is to assess the taste properties of HIV inhibitor

Enrollment

8 patients

Sex

All

Ages

25 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

  • Men and women of non-childbearing potential professional sensory panelists
  • Aged between 25 and 80 years

Exclusion Criteria:

  • History of relevant drug or food allergies, cardiovascular or Central nervous system (CNS) disease, clinically significant pathology, history of mental illness
  • Positive HIV test

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

BMS-955176
Experimental group
Description:
BMS-955176 specified dose on specified days
Treatment:
Drug: BMS-955176

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems